NutraMax
This article was originally published in The Tan Sheet
Executive Summary
OTC private labeler faces threatened delisting of its common stock by NASDAQ for delayed reporting of third quarter and nine-month financial results for the periods ended July 3. NASDAQ informed the Gloucester, Mass.-based company it must satisfy continued listing criteria. Any delisting has been stayed pending a NutraMax-requested hearing, expected to occur in the next several weeks. The company says a physical inventory and additional accounting procedures have delayed reporting of its results (1"The Tan Sheet" Aug. 30, p. 14)